Larvol Delta - Inhibikase-Therapeutics-IKT-Announces-Advancement-of-IkT148009-Phase-2-3920139-Program-Following-FDA-Review

IkT-148009 - Inhibikase, Clintrex

https://www.streetinsider.com/Corporate+News/Inhibikase+Therapeutics+%28IKT%29+Announces+Advancement+of+IkT-148009+Phase+2+201+Program+Following+FDA+Review/20205307.html

Jun 13, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next